New cannabis rules boost medical-only profits while challenging multi-state operators.

These companies are major players in the U.S. marijuana market, and they all generated more than $1 billion in revenue last ...

Cannabis stocks often trade less on traditional fundamentals alone and more on changes in policy. Cannabis ETFs are a narrow ...

MSOS's metric understates risk by excluding large tax liabilities, especially for CURLF and TCNNF. Learn more about the MSOS ...

Cannabis multi-state operators, which surged Wednesday following a report that marijuana would be reclassified as a Schedule ...

Cannabis ETFs entered 2026 after multiple fund closures, stalled federal reform, and a prolonged multi‑year drawdown in underlying equities. The contraction of the product lineup has left a smaller ...

Sun, January 18, 2026 at 3:59 PM UTC The AdvisorShares Pure US Cannabis ETF has spent the last month on a rollercoaster. After climbing to $6.45 in mid-December 2025, shares dropped 26% to around ...

Will the rescheduling of cannabis fuel a boom in cannabis stocks? Analysts from Z&A delve into the pros and cons of MSOs and cannabis rescheduling in their latest equity research report. Re-scheduling ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

AdvisorShares Pure US Cannabis ETF (MSOS) dropped 26% to $4.80 by mid-January despite Trump’s December executive order. MSOS holds $921M and gains exposure to Curaleaf and Trulieve through swap ...